You need more information?
Get in Touch with IPA
IPA is a global non-profit organization that advocates for the safe and efficacious use of Pre-, Pro- and Post- biotics. We bring together the knowledge and resources of scientists, healthcare professionals, academics and regulators to define clear standards that advance the quality of Pre-, Pro- and Post- biotics.
3484 Boul. Des Sources, Suite 320, Dollard des Ormeaux, Quebec H9B 1Z9, CA
December 25, 2019
Butyrate in Colorectal Cancer
Amidst the cluster of short-chain fatty acids (SCFAs), butyrate is a stand-out. Gut bacteria create helpful amounts of this SCFA from soluble fibers such as inulin. This has lead researchers to try to define its benefit in diseases.
Dysbiosis in colorectal cancer
Changes in the bacterial composition of the gut have been reported in colorectal cancer, proposing a key role of dysbiosis. Still murky however is whether these differences are drivers or responses to cancer.
However, the interplay between forces favorable to cancer and those attempting to thwart it makes for meaningful research and a possible role for probiotics.
A marked reduction in butyrate-producing bacteria has been observed in patients with colorectal cancer. Researchers recently asked whether butyrate-producing bacteria could reduce intestinal tumor development in mice. Gut microbiota dysbiosis is closely involved in intestinal carcinogenesis was published in Science Direct online in November 2019.
Butyrate-producing bacteria, a study
The study used mice which developed intestinal tumors from a high-fat diet.
Clostridium butyricum (C. butyricum), one of the commonly used butyrate-producing bacteria in clinical settings, significantly inhibited tumor development in these types of mice.
Interestingly, intestinal tumor cells treated with C. butyricum exhibited decreased proliferation and increased apoptosis.
Moreover, C. butyricum modulated the gut microbiota composition, as demonstrated by decreases in some pathogenic bacteria and bile acid biotransforming bacteria and increases in some beneficial bacteria, including short-chain fatty acid (SCFA)-producing bacteria.
The mice also showed gene changes. The bacteria C. butyricum activated G-protein coupled receptors. The analysis of clinical specimens revealed that the expression of receptors gradually decreased from human normal colonic tissue to adenoma to carcinoma.
“Together, our results show that C. butyricum can inhibit intestinal tumor development by modulating Wnt signaling and gut microbiota and thus suggest the potential efficacy of butyrate-producing bacteria against CRC.”
Takeaway
Given the potential benefits of butyrate-producing bacteria, we should feed them their fuel of choice. Add more prebiotics such as inulin to your menus.
Best sources of inulin
- Bananas
- Garlic
- Onions
- Dandelion greens
- Leeks
- Asparagus
You may also like
Biotic Deep Dive
Probiotics for Hypertension: What Science Says
Over 1.4 billion adults globally live with hypertension (HTN) or high blood pressure, yet nearly half are unaware they have it, leaving many undiagnosed and untreated. This silent condition carries...
November 19, 2025
See more
Biotic Deep Dive
Hidden Dangers in Food and Environment: Pesticides and Gut Health
As the global population grows and food demand surges, farmers rely heavily on pesticides to boost crop yields and safeguard food quality—practices that have delivered undeniable economic benefits. But these...
November 5, 2025
See more
Biotic Deep Dive
Microbiome Modulation: A New Frontier in Wound Management
Skin wounds open the door for harmful organisms, risking infection and disrupting the skin’s microbial balance. Initial care typically involves thorough cleaning and disinfection to prevent infection. While antibiotics are...
October 18, 2025
See more